PIBAX
Price
$18.38
Change
+$0.04 (+0.22%)
Updated
Dec 24 closing price
Net Assets
1.06B
RLBBX
Price
$37.32
Change
+$0.14 (+0.38%)
Updated
Dec 24 closing price
Net Assets
269.37B
Interact to see
Advertisement

PIBAX vs RLBBX

Header iconPIBAX vs RLBBX Comparison
Open Charts PIBAX vs RLBBXBanner chart's image
PGIM Balanced A
Price$18.38
Change+$0.04 (+0.22%)
VolumeN/A
Net Assets1.06B
American Funds American Balanced R2
Price$37.32
Change+$0.14 (+0.38%)
VolumeN/A
Net Assets269.37B
PIBAX vs RLBBX Comparison Chart in %
View a ticker or compare two or three
VS
PIBAX vs. RLBBX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PIBAX is a StrongBuy and RLBBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 269B vs. PIBAX (1.06B). PIBAX pays higher dividends than RLBBX: PIBAX (1.93) vs RLBBX (1.07). PIBAX was incepted earlier than RLBBX: PIBAX (29 years) vs RLBBX (24 years). RLBBX (1.32) is less costly to investors than PIBAX (1.12). PIBAX is a more actively managed with annual turnover of: 107.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than PIBAX: RLBBX (250) vs PIBAX (1000). RLBBX annual gain was more profitable for investors over the last year : 8.55 vs. PIBAX (6.30). RLBBX return over 5 years is better than : 30.71 vs. PIBAX (15.90).
PIBAXRLBBXPIBAX / RLBBX
Total Expense Ratio1.001.3276%
Annual Report Gross Expense Ratio1.121.3285%
Fund Existence29 years24 years-
Gain YTD7.6559.98977%
Front Load3%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B269B0%
Annual Yield % from dividends1.931.07181%
Returns for 1 year6.308.5574%
Returns for 3 years34.4034.8199%
Returns for 5 years15.9030.7152%
Returns for 10 years48.0965.9773%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSEE0.470.01
+1.51%
VSee Health Inc.
BCSF13.820.16
+1.17%
Bain Capital Specialty Finance
ENVA164.671.53
+0.94%
Enova International
VTR79.620.51
+0.64%
Ventas
SABS3.84N/A
N/A
SAB Biotherapeutics